Member Info for Tornadotony

Elias

I believe the 8.8 million figure in those hills has the charm of the Irish talk. Needs to proven with a lot more exploration.

Tony

This should go up regardless of RNS.

In the afternoon yesterday it was 159 support and 240 resistance.

I think it is low expenditure outlay for what is a recoverable venture but I am not sure it will generate much profit. Upside of $5M say later on. I would be surprised if the share has any significant response. Should hold 136p and travel up to 138p because of commodity prices and nothing for much for this RNS.

With Conroy Gold in Eire. t diversifies the company. AAZ helping to build a mine. Geological similarities to its existing mines. JORC has 500,000 ounces of gold plus additional exploration for a possible 7.5M ounces. AAZ says it does not detract for on-going plans.

Bought 170p and then at 159p on the dip. Sold half at 192p. So my original stake is now equivalent at 140p. The idea is to build up trade profits to reverse engineer a good entry that I missed and some of the really clever folk had from the very start on here. Hence why this may be up and down like a yoyo.

Banks not backs not sure how that typo crept in.

Evidently

When I read the RNS, it did seem a little strange to be involving China when the Angola facility provides an alternative route to market. Then the following thoughts came to my mind. The document agreed is some kind of heads of agreement. How binding it is may depend what was actually worded and being promised. Secondly , the Chinese are really good at building plant infrastructure and the company wants this built well and on time. Finding a company to do this is either Chinese or Canadian for rare elements if its out to subcontract. With this document published is anyone else going to provide all the building of the mine, the finance package and insurance cover if things go wrong. Some backs expect 9-10% interest repayment. I am not sure what the Chinese rate is and that is something we will learn about later on. The company has expressed a desire for a one stop shop for the whole lot.

Another factor is that China may well want to restrict rare metals exports as its own national market demand increases greatly for it and this simply limits the amount for other markets. Therefore they do not see it as such a competitive issues by supporting other rare metal producers and they may want a good relationship with Angola as well.

The share has gone up as the debt package and the future selling of Tanzania gold mine is likely to limit the extent of any placings on equity owners.

Hope those views help. Tony

I am very satisfied with the RNS and believe its a strong growth stock. I can see this share at 24-25p in the future as production increases. My 3 miners, Shanta (Tanzania), AAZ (Azerbaijan) and Pensana (Angola and Tanzania) all have some promise.

This is going up. Now have a useful holding.

kwaboy

Only one person knows the correct answer to that question and its you. You know how much percentage of your wealth was invested and how big the risk was taken by you. There is no rule that you can not titrate in buys and titrate out sells.

Although a number of companies provide injected materials to help MS and other patient diseases, I can not find any source that gives the medication through an aspirated route to the lungs. A drug delivery mechanism with interferon beta 1A together is what makes this unique.

Thanks for putting that info on as I am still catching up on this company.

AstraZenica is upward bound as well.

Averaged down with 159p buy. Now I have managed to learn a lot more about the product.

https://r.search.yahoo.com/_ylt=AwrJQ6D8lBVfWwUAjScM34lQ;_ylu=X3oDMTBydWZibG83BGNvbG8DaXIyBHBvcwM4BHZ0aWQDBHNlYwNzcg--/RV=2/RE=1595278717/RO=10/RU=https%3a%2f%2fwww.synairgen.com%2fwp-content%2fuploads%2f2018%2f06%2f15812_sy_annualreport_2012_web.pdf/RK=2/RS=CDHVhli3xhPl67FbGCQpc9vUiuQ-

USA patent and others regarding SNG001 dated back in 2012 have not got time to read it all.

https://www.astrazeneca.com/media-centre/press-releases/2014/astrazeneca-synairgen-sng001-novel-immuno-modulatory-therapy-asthma-12062014.html#

To be able to offer a licence to another company like Astrazenca implies that SNG001 has a patent. The use had a another purpose and under USA patent law another company can probably seek a licence from Synairgen to produce in the USA for that reason. If somebody knows different please let us know,

This is crazy one minute I had a nice profit and now all gone. Will still keep my 1000 as I think this team have something very valuable. Patents can be very expensive to buy or they yield a nice income if sold under licence use.

Happy to buy any sellers shares. If you made a lot of pie let some of us newbies have a little.

One of the top places for pharmacogenetics and Health Technology Assessment in the country. I would be astounded if peer review found anything wrong in the conduct of the trial. The people leading this are extremely competent.